_version_ 1785134964488011776
author Ngai, Lok Lam
Hanekamp, Diana
Janssen, Fleur
Carbaat-Ham, Jannemieke
Hofland, Maaike A. M. A.
Fayed, Mona M. H. E
Kelder, Angèle
Oudshoorn-van Marsbergen, Laura
Scholten, Willemijn J.
Snel, Alexander N.
Bachas, Costa
Tettero, Jesse M.
Breems, Dimitri A.
Fischer, Thomas
Gjertsen, Bjørn T.
Griškevičius, Laimonas
Juliusson, Gunnar
van de Loosdrecht, Arjan A.
Maertens, Johan A.
Manz, Markus G.
Pabst, Thomas
Passweg, Jakob R.
Porkka, Kimmo
Valk, Peter J. M.
Gradowska, Patrycja
Löwenberg, Bob
de Leeuw, David C.
Janssen, Jeroen J. W. M.
Ossenkoppele, Gert J.
Cloos, Jacqueline
author_facet Ngai, Lok Lam
Hanekamp, Diana
Janssen, Fleur
Carbaat-Ham, Jannemieke
Hofland, Maaike A. M. A.
Fayed, Mona M. H. E
Kelder, Angèle
Oudshoorn-van Marsbergen, Laura
Scholten, Willemijn J.
Snel, Alexander N.
Bachas, Costa
Tettero, Jesse M.
Breems, Dimitri A.
Fischer, Thomas
Gjertsen, Bjørn T.
Griškevičius, Laimonas
Juliusson, Gunnar
van de Loosdrecht, Arjan A.
Maertens, Johan A.
Manz, Markus G.
Pabst, Thomas
Passweg, Jakob R.
Porkka, Kimmo
Valk, Peter J. M.
Gradowska, Patrycja
Löwenberg, Bob
de Leeuw, David C.
Janssen, Jeroen J. W. M.
Ossenkoppele, Gert J.
Cloos, Jacqueline
author_sort Ngai, Lok Lam
collection PubMed
description [Figure: see text]
format Online
Article
Text
id pubmed-10646801
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher The American Society of Hematology
record_format MEDLINE/PubMed
spelling pubmed-106468012023-03-15 Prospective validation of the prognostic relevance of CD34(+)CD38(–) AML stem cell frequency in the HOVON-SAKK132 trial Ngai, Lok Lam Hanekamp, Diana Janssen, Fleur Carbaat-Ham, Jannemieke Hofland, Maaike A. M. A. Fayed, Mona M. H. E Kelder, Angèle Oudshoorn-van Marsbergen, Laura Scholten, Willemijn J. Snel, Alexander N. Bachas, Costa Tettero, Jesse M. Breems, Dimitri A. Fischer, Thomas Gjertsen, Bjørn T. Griškevičius, Laimonas Juliusson, Gunnar van de Loosdrecht, Arjan A. Maertens, Johan A. Manz, Markus G. Pabst, Thomas Passweg, Jakob R. Porkka, Kimmo Valk, Peter J. M. Gradowska, Patrycja Löwenberg, Bob de Leeuw, David C. Janssen, Jeroen J. W. M. Ossenkoppele, Gert J. Cloos, Jacqueline Blood Letter to Blood [Figure: see text] The American Society of Hematology 2023-05-25 2023-03-15 /pmc/articles/PMC10646801/ /pubmed/36898087 http://dx.doi.org/10.1182/blood.2022019160 Text en © 2023 by The American Society of Hematology. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Letter to Blood
Ngai, Lok Lam
Hanekamp, Diana
Janssen, Fleur
Carbaat-Ham, Jannemieke
Hofland, Maaike A. M. A.
Fayed, Mona M. H. E
Kelder, Angèle
Oudshoorn-van Marsbergen, Laura
Scholten, Willemijn J.
Snel, Alexander N.
Bachas, Costa
Tettero, Jesse M.
Breems, Dimitri A.
Fischer, Thomas
Gjertsen, Bjørn T.
Griškevičius, Laimonas
Juliusson, Gunnar
van de Loosdrecht, Arjan A.
Maertens, Johan A.
Manz, Markus G.
Pabst, Thomas
Passweg, Jakob R.
Porkka, Kimmo
Valk, Peter J. M.
Gradowska, Patrycja
Löwenberg, Bob
de Leeuw, David C.
Janssen, Jeroen J. W. M.
Ossenkoppele, Gert J.
Cloos, Jacqueline
Prospective validation of the prognostic relevance of CD34(+)CD38(–) AML stem cell frequency in the HOVON-SAKK132 trial
title Prospective validation of the prognostic relevance of CD34(+)CD38(–) AML stem cell frequency in the HOVON-SAKK132 trial
title_full Prospective validation of the prognostic relevance of CD34(+)CD38(–) AML stem cell frequency in the HOVON-SAKK132 trial
title_fullStr Prospective validation of the prognostic relevance of CD34(+)CD38(–) AML stem cell frequency in the HOVON-SAKK132 trial
title_full_unstemmed Prospective validation of the prognostic relevance of CD34(+)CD38(–) AML stem cell frequency in the HOVON-SAKK132 trial
title_short Prospective validation of the prognostic relevance of CD34(+)CD38(–) AML stem cell frequency in the HOVON-SAKK132 trial
title_sort prospective validation of the prognostic relevance of cd34(+)cd38(–) aml stem cell frequency in the hovon-sakk132 trial
topic Letter to Blood
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10646801/
https://www.ncbi.nlm.nih.gov/pubmed/36898087
http://dx.doi.org/10.1182/blood.2022019160
work_keys_str_mv AT ngailoklam prospectivevalidationoftheprognosticrelevanceofcd34cd38amlstemcellfrequencyinthehovonsakk132trial
AT hanekampdiana prospectivevalidationoftheprognosticrelevanceofcd34cd38amlstemcellfrequencyinthehovonsakk132trial
AT janssenfleur prospectivevalidationoftheprognosticrelevanceofcd34cd38amlstemcellfrequencyinthehovonsakk132trial
AT carbaathamjannemieke prospectivevalidationoftheprognosticrelevanceofcd34cd38amlstemcellfrequencyinthehovonsakk132trial
AT hoflandmaaikeama prospectivevalidationoftheprognosticrelevanceofcd34cd38amlstemcellfrequencyinthehovonsakk132trial
AT fayedmonamhe prospectivevalidationoftheprognosticrelevanceofcd34cd38amlstemcellfrequencyinthehovonsakk132trial
AT kelderangele prospectivevalidationoftheprognosticrelevanceofcd34cd38amlstemcellfrequencyinthehovonsakk132trial
AT oudshoornvanmarsbergenlaura prospectivevalidationoftheprognosticrelevanceofcd34cd38amlstemcellfrequencyinthehovonsakk132trial
AT scholtenwillemijnj prospectivevalidationoftheprognosticrelevanceofcd34cd38amlstemcellfrequencyinthehovonsakk132trial
AT snelalexandern prospectivevalidationoftheprognosticrelevanceofcd34cd38amlstemcellfrequencyinthehovonsakk132trial
AT bachascosta prospectivevalidationoftheprognosticrelevanceofcd34cd38amlstemcellfrequencyinthehovonsakk132trial
AT tetterojessem prospectivevalidationoftheprognosticrelevanceofcd34cd38amlstemcellfrequencyinthehovonsakk132trial
AT breemsdimitria prospectivevalidationoftheprognosticrelevanceofcd34cd38amlstemcellfrequencyinthehovonsakk132trial
AT fischerthomas prospectivevalidationoftheprognosticrelevanceofcd34cd38amlstemcellfrequencyinthehovonsakk132trial
AT gjertsenbjørnt prospectivevalidationoftheprognosticrelevanceofcd34cd38amlstemcellfrequencyinthehovonsakk132trial
AT griskeviciuslaimonas prospectivevalidationoftheprognosticrelevanceofcd34cd38amlstemcellfrequencyinthehovonsakk132trial
AT juliussongunnar prospectivevalidationoftheprognosticrelevanceofcd34cd38amlstemcellfrequencyinthehovonsakk132trial
AT vandeloosdrechtarjana prospectivevalidationoftheprognosticrelevanceofcd34cd38amlstemcellfrequencyinthehovonsakk132trial
AT maertensjohana prospectivevalidationoftheprognosticrelevanceofcd34cd38amlstemcellfrequencyinthehovonsakk132trial
AT manzmarkusg prospectivevalidationoftheprognosticrelevanceofcd34cd38amlstemcellfrequencyinthehovonsakk132trial
AT pabstthomas prospectivevalidationoftheprognosticrelevanceofcd34cd38amlstemcellfrequencyinthehovonsakk132trial
AT passwegjakobr prospectivevalidationoftheprognosticrelevanceofcd34cd38amlstemcellfrequencyinthehovonsakk132trial
AT porkkakimmo prospectivevalidationoftheprognosticrelevanceofcd34cd38amlstemcellfrequencyinthehovonsakk132trial
AT valkpeterjm prospectivevalidationoftheprognosticrelevanceofcd34cd38amlstemcellfrequencyinthehovonsakk132trial
AT gradowskapatrycja prospectivevalidationoftheprognosticrelevanceofcd34cd38amlstemcellfrequencyinthehovonsakk132trial
AT lowenbergbob prospectivevalidationoftheprognosticrelevanceofcd34cd38amlstemcellfrequencyinthehovonsakk132trial
AT deleeuwdavidc prospectivevalidationoftheprognosticrelevanceofcd34cd38amlstemcellfrequencyinthehovonsakk132trial
AT janssenjeroenjwm prospectivevalidationoftheprognosticrelevanceofcd34cd38amlstemcellfrequencyinthehovonsakk132trial
AT ossenkoppelegertj prospectivevalidationoftheprognosticrelevanceofcd34cd38amlstemcellfrequencyinthehovonsakk132trial
AT cloosjacqueline prospectivevalidationoftheprognosticrelevanceofcd34cd38amlstemcellfrequencyinthehovonsakk132trial